Approval · Notice of Compliance 3566 · 2003
ALDACTONE: Notice of Compliance 3566
Issued September 15, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3566
- Date
- September 15, 2003
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Aldosterone antagonist
Products in this notice
Medicinal ingredients
- SPIRONOLACTONE 25 MG per TAB
- SPIRONOLACTONE 100 MG per TAB